Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer

Clinical trial NCT06604858 · COMPLETED

Trial details

NCT number: NCT06604858
Sponsor: MedSIR
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Triple Negative Breast Cancer

Start date: 2025-05-29
Primary completion: 2026-07-07
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.